Abstract |
Fractionation by reversed-phase HPLC of venom from four species of saw-scaled viper: Echis ocellatus, Echis pyramidum leakeyi, Echis carinatus sochureki, and Echis coloratus led to identification in each sample of an abundant protein with cytotoxic activity against human non-small cell lung adenocarcinoma A549 cells. The active component in each case was identified by MALDI-TOF mass fingerprinting of tryptic digests as [Ser⁴⁹] phospholipase A₂ ([Ser⁴⁹]PLA₂). An isoform of [Ser⁴⁹]PLA₂ containing the single Ala¹⁸→ Val substitution and a partially characterized [Asp⁴⁹]PLA₂ were also present in the E. coloratus venom. LC₅₀ values against A549 cells for the purified [Ser⁴⁹]PLA₂ proteins from the four species are in the range 2.9-8.5 μM. This range is not significantly different from the range of LC₅₀ values against human umbilical vein endothelial HUVEC cells (2.5-12.2 μM) indicating that the [Ser⁴⁹]PLA₂ proteins show no differential anti- tumor activity. The LC₅₀ value for [Ser⁴⁹]PLA₂ from E. ocellatus against human erythrocytes is >100 μM and the MIC values against Escherichia coli and Staphylococcus aureus are >100 μM. It is suggested that the [Ser⁴⁹]PLA₂ proteins play a major role in producing local tissue necrosis and hemorrhage at the site of envenomation.
|
Authors | J Michael Conlon, Samir Attoub, Hama Arafat, Milena Mechkarska, Nicholas R Casewell, Robert A Harrison, Juan J Calvete |
Journal | Toxicon : official journal of the International Society on Toxinology
(Toxicon)
Vol. 71
Pg. 96-104
(Sep 2013)
ISSN: 1879-3150 [Electronic] England |
PMID | 23747272
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Anti-Bacterial Agents
- Antineoplastic Agents
- Viper Venoms
- Phospholipases A2
|
Topics |
- Amino Acid Sequence
- Animals
- Anti-Bacterial Agents
(pharmacology)
- Antineoplastic Agents
(pharmacology)
- Chromatography, High Pressure Liquid
- Erythrocytes
(drug effects, metabolism)
- Escherichia coli
(drug effects, growth & development)
- Human Umbilical Vein Endothelial Cells
(drug effects, metabolism)
- Humans
- Inhibitory Concentration 50
- Molecular Sequence Data
- Phospholipases A2
(isolation & purification, pharmacology)
- Snake Bites
(pathology)
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Staphylococcus aureus
(drug effects, growth & development)
- Viper Venoms
(pharmacology)
- Viperidae
(classification)
|